Intuitive Surgical (ISRG) Wins EU Approval As Its Undervalued Narrative Faces A Fresh Test

Intuitive Surgical (ISRG) just secured CE mark approval for transvaginal gynecologic procedures on its da Vinci SP system in Europe, a world first that broadens the platform’s minimally invasive surgery footprint.

That regulatory win lands at an interesting moment for Intuitive Surgical, with the stock at US$383.54 after a 6.4% 7-day share price return but a year-to-date share price decline of 31.75%, while the 3-year total shareholder return of 34.88% points to much stronger longer run compounding.

Scan the broader robotics opportunity around Intuitive Surgical by reviewing the curated 95 robotics and automation stocks that could benefit as surgical systems and automation gain more attention from hospitals worldwide.

Bulls point to Intuitive Surgical’s CE mark win and recurring model. Bears focus on the rich P/E multiple after a sharp drawdown. Which side does the current valuation lean toward?

Most Popular Narrative: 19.8% Undervalued

Against the last close at $383.54, the most widely followed narrative pegs Intuitive Surgical’s fair value at $478.01. This frames the current setup as discounted and heavily tied to procedure utilization, software, and automation over time.

Ongoing product innovation (including full launch of da Vinci 5, integrated force feedback, and digital/AI case insights), coupled with R&D to expand into adjacent specialties, enhances clinical outcomes and surgeon efficiency, supporting future procedure growth, higher system ASPs, and increased recurring instrument and accessory revenues.

See why 233 investors see Intuitive Surgical as 20% undervalued.

Result: Fair Value of $478.01 (UNDERVALUED)

Still, that 31.75% year to date share price decline, along with rising competitive and reimbursement pressures around Intuitive Surgical, could easily challenge this underpriced story.

Find out about the key risks to this Intuitive Surgical narrative.

Another View: Intuitive Surgical Looks Expensive On Earnings

On the flip side of that fair value argument, Intuitive Surgical trades on a P/E of 43.2x. The broader US Medical Equipment industry sits at 24.8x and similar peers average 25.4x, while the fair ratio is estimated at 35.5x, which points to meaningful valuation risk if sentiment cools.

For investors weighing that gap, the question is simple: Does Intuitive Surgical’s growth, cash generation, and recurring model justify paying such a premium, or could the share price drift closer to that fair ratio if expectations ease?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If the mixed sentiment on Intuitive Surgical has you torn, move fast and stress test the story against the underlying data yourself, starting with 3 key rewards.

Looking for more Intuitive Surgical investment ideas?

If Intuitive Surgical has you thinking bigger, do not stop here. Use the Simply Wall Street Screener to spot fresh opportunities before everyone else catches on.

• Target resilient upside by scanning a 30 resilient stocks with low risk scores that can help you focus on companies with steadier risk profiles.
• Hunt for quality at a discount by reviewing a curated 16 high quality undiscovered gems that might not yet be on most investors' radar.
• Build a sturdier core for your portfolio by filtering a list of solid balance sheet and fundamentals (23 results) before prices move away from you.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com